Up to KRW 13 billion in funding
Participating as a commissioned institution

Hanyang University ERICA's research team will participate as a commissioned institution in a KRW 13 billion Korean ARPA-H project to develop a care platform for managing depression among older adults.

Participants at the 2026 Korea ARPA-H project kickoff meeting pose for a commemorative photo. Hanyang University.

Participants at the 2026 Korea ARPA-H project kickoff meeting pose for a commemorative photo. Hanyang University.

View original image

Hanyang University said on the 23rd that a research team led by Professor Kim Seong-gwon of the Division of ICT Convergence at the College of Software Convergence (Digital Healthcare Laboratory) will participate as a commissioned institution in the Korean ARPA-H Project. The team will develop a care platform based on a non-invasive brain-computer interface (BCI) to manage depression among older adults.


The Korean ARPA-H Project is a research and development program supported by the Ministry of Health and Welfare and the K-Health Future Promotion Group at the Korea Health Industry Development Institute. Its goal is to develop mental health care services for older adults that can be used in real-life settings.


The selected project is a subproject of “Advancing the System for Extracting Brain-Change Data for Older Adults' Mental Health and Developing a Platform to Provide Optimized Non-Disruptive Interventions” (project name: BCI-INSIDE-OUT). It will receive up to KRW 13 billion in research funding. The research period runs from July 2026 through December 2030.



Key participants in the research from the medical, artificial intelligence (AI), and BCI fields include Yonsei University Wonju Severance Christian Hospital, Hanyang University ERICA, Gachon University, Pusan National University, BioNexus, Upstage, Lulumedic, and Peach Life Sciences.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing